Page last updated: 2024-08-21

malondialdehyde and Scleroderma, Systemic

malondialdehyde has been researched along with Scleroderma, Systemic in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's2 (18.18)18.2507
2000's5 (45.45)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ansari, GAS; Khan, MF; Wang, G; Wang, J1
Clifton, HL; Donato, AJ; Frech, TM; Groot, HJ; Machin, DR; Richardson, RS; Wray, DW1
Jiang, M; Liu, X; Luo, JY; Zhao, HP; Zhao, JJ1
Devrim, E; Durak, I; Erguder, IB; Erten, S; Namuslu, M; Turgay, M1
Bagchi, D; Cerinic, MM; Das, DK; Del Rosso, A; Generini, S; Kalin, R; Righi, A1
Allanore, Y; Borderie, D; Ekindjian, OG; Kahan, A; Lemaréchal, H1
Channa, K; Gulumian, M; Theodorou, P; Tikly, M1
Balbir-Gurman, A; Boikaner, T; Braun-Moscovici, Y; Livshitz, V; Markovits, D; Nahir, AM; Rozin, A; Schapira, D1
Auclair, C; Deroussent, A; Emerit, I; Fernandes, A; Filipe, P; Freitas, J; Gouyette, A; Meunier, P1
Bancroft, A; Belch, JJ; Bridges, AB; Lau, CS; Muir, A; Scott, N1
Kudriavtseva, GV; Makarov, SA; Shishkin, VI1

Reviews

1 review(s) available for malondialdehyde and Scleroderma, Systemic

ArticleYear
Oxidative stress markers in blood in systemic sclerosis: A meta-analysis.
    Modern rheumatology, 2017, Volume: 27, Issue:2

    Topics: Arginine; Ascorbic Acid; Biomarkers; Case-Control Studies; Humans; Malondialdehyde; Nitric Oxide; Oxidative Stress; Scleroderma, Systemic; Superoxide Dismutase

2017

Trials

2 trial(s) available for malondialdehyde and Scleroderma, Systemic

ArticleYear
Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis.
    The American journal of medicine, 2004, May-01, Volume: 116, Issue:9

    Topics: Adult; Aged; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Scleroderma, Systemic; Sulfhydryl Compounds; Time Factors

2004
Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis.
    Clinical rheumatology, 2007, Volume: 26, Issue:9

    Topics: Adult; Antioxidants; Catalase; Ceruloplasmin; Female; Humans; Iloprost; Malondialdehyde; Middle Aged; Oxidative Stress; Platelet Aggregation Inhibitors; Raynaud Disease; Scleroderma, Systemic; Superoxide Dismutase

2007

Other Studies

8 other study(ies) available for malondialdehyde and Scleroderma, Systemic

ArticleYear
Autoimmune potential of perchloroethylene: Role of lipid-derived aldehydes.
    Toxicology and applied pharmacology, 2017, 10-15, Volume: 333

    Topics: Animals; Antibodies; Autoimmunity; Cell Proliferation; Disease Models, Animal; Female; Glutathione; Interleukin-17; Lipids; Lupus Erythematosus, Systemic; Malondialdehyde; Mice; Protein Binding; Scleroderma, Systemic; Solvents; Spleen; Superoxide Dismutase; Tetrachloroethylene; Th17 Cells

2017
Attenuated nitric oxide bioavailability in systemic sclerosis: Evidence from the novel assessment of passive leg movement.
    Experimental physiology, 2018, Volume: 103, Issue:10

    Topics: Biological Availability; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Humans; Inflammation; Leg; Male; Malondialdehyde; Middle Aged; Movement; Nitric Oxide; Oxidative Stress; Regional Blood Flow; Scleroderma, Systemic

2018
Malondialdehyde and nitric oxide levels in erythrocytes from patients with systemic sclerosis.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2008, Volume: 17, Issue:4

    Topics: Antioxidants; Case-Control Studies; Erythrocytes; Fasting; Female; Humans; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Oxidative Stress; Scleroderma, Systemic

2008
Activin, a grape seed-derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis.
    Free radical research, 2002, Volume: 36, Issue:8

    Topics: Activins; Anthocyanins; Cell Adhesion; E-Selectin; Humans; Inflammation; Intercellular Adhesion Molecule-1; Malondialdehyde; Models, Chemical; Oxidative Stress; Pilot Projects; Plant Extracts; Proanthocyanidins; Scleroderma, Systemic; Seeds; Vascular Cell Adhesion Molecule-1; Vitis

2002
Lipid peroxidation and trace elements in systemic sclerosis.
    Clinical rheumatology, 2006, Volume: 25, Issue:3

    Topics: Case-Control Studies; Disability Evaluation; Female; Health Status; Humans; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Scleroderma, Systemic; Skin; Surveys and Questionnaires; Time Factors; Trace Elements

2006
Clastogenic activity in the plasma of scleroderma patients: a biomarker of oxidative stress.
    Dermatology (Basel, Switzerland), 1997, Volume: 194, Issue:2

    Topics: Adenosine Deaminase; Adult; Aged; Antioxidants; Biomarkers; Colorimetry; Electrochemistry; Esophageal Diseases; Female; Humans; Inosine Triphosphate; Lipid Peroxidation; Male; Malondialdehyde; Mass Spectrometry; Middle Aged; Mutagens; Oxidative Stress; Scleroderma, Systemic; Skin Diseases; Superoxide Dismutase; Superoxides

1997
Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon.
    British journal of rheumatology, 1992, Volume: 31, Issue:6

    Topics: Adult; Aged; Cell Adhesion; Female; Humans; Male; Malondialdehyde; Middle Aged; Neutrophils; Raynaud Disease; Scleroderma, Systemic; Severity of Illness Index

1992
[Prostaglandins in the pathogenesis of various systemic diseases of the connective tissue].
    Terapevticheskii arkhiv, 1987, Volume: 59, Issue:4

    Topics: Adult; Arthritis, Rheumatoid; Connective Tissue Diseases; Female; Humans; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Prostaglandins; Scleroderma, Systemic

1987
chemdatabank.com